The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: November 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

1. Mitotic clustering of pulverized chromosomes from micronuclei

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next

Lin, Y-F. et al. Nature. 618: 1041-1048 (2023).
doi: doi.org/10.1038/s41586-023-05974-0.

Summary of the findings

Cancer genomes commonly harbor complex rearrangements driven by chromothripsis, the catastrophic shattering and reassembly of individual chromosomes. Chromothripsis can be initiated by mitotic errors that entrap mis-segregated chromosomes within micronuclei, which are susceptible to DNA damage and replication defects that lead to chromosome shattering in the subsequent mitosis. Most of the chromosomal fragments are then reassembled in random order to generate rearrangements. However, since most fragments lack a centromere and cannot attach to spindle microtubules, how shattered chromosomes undergo segregation during mitosis and reincorporation into daughter cell genomes was unknown. Lin et al. report that shattered chromosomes cluster in spatial proximity during mitosis, which biases fragment distribution toward one daughter cell. The authors identify the CIP2A–TOPBP1 complex as the mitotic tether, the inactivation of which disperses fragments throughout the mitotic cytoplasm.
Since shattered chromosomes are mostly inherited by one daughter cell, these findings predict that some cancer genomes would exhibit complex rearrangements lacking changes in DNA copy-number. Indeed, such copy-number-neutral rearrangements, termed balanced chromothripsis, are found in ~5% of diverse tumors and underpin the acquisition of recurrent driver events, including fusion oncogenes. This work highlights a mechanism that drives specific patterns of genome rearrangements from an initial chromosome segregation error.
CIP2A-TOPBP1-mediated mitotic clustering of pulverized chromosomes from micronuclei facilitates balanced rearrangements in one of the daughter cells following mother cell division. In the absence of CIP2A-TOPBP1, pulverized fragments disperse throughout the mitotic cytoplasm and stochastically partition into both daughter cells. The figure and figure legend were taken from Extended Data Figure 11 from the original article (https://www.nature.com/articles/s41586-023-05974-0#Sec30) published Open Access under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).

Future impact

It remains unclear what are the precise DNA lesion(s) that recruit CIP2A and TOPBP1 to micronuclei during interphase and/or to shattered chromosomes in mitosis. Additionally, further mechanistic studies are needed to determine how this protein complex functions to tether chromosome fragments, whether other unidentified components are involved, and how these processes are regulated in diverse contexts. Lastly, further investigation is needed to define the impact of balanced chromothripsis on cancer genome evolution and tumorigenesis.

Read more in Nature

1. Mitotic clustering of pulverized chromosomes from micronuclei

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: December 2025

December 8, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship
News

Amel Aziba receives EACR-Molecular Oncology Editorial Fellowship

February 2, 2026
“Instrumental during my PhD journey”: Àlex Cebrià Xart’s EACR Travel Fellowship
Community

“Instrumental during my PhD journey”: Àlex Cebrià Xart’s EACR Travel Fellowship

January 30, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR